A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found shortening a traditional 45-day course of radiation to a five-day course delivered in larger doses is safe and as effective as conventional radiation for men with high-risk forms of prostate cancer.
Plans to build a world-class, acute care hospital on the northern edge of the University of California, Irvine academic campus advanced significantly today, as the University of California Board of Regents granted approval of the project’s 144-bed acute care facility, ambulatory care center and cancer center. The hospital joins the…
Since the beginning of the COVID-19 pandemic, UCI and UCI Health have been committed to leading our community’s fight against the disease. Last weekend, UCI Health began offering the COVID-19 vaccine to more than 2,700 UCI Health patients 65 years of age and older on the UCI campus in Irvine…
UC San Diego study supports launch of Phase I clinical trial to test a designer DNA agent — an antisense oligonucleotide that targets a gene called IRF4 — in patients with multiple myeloma.
The University of California, Riverside, expects to receive a shipment of 400 Moderna COVID-19 vaccine doses on Wednesday, Jan. 20. An initial shipment of 100 Moderna vaccines was delivered to Student Health Services earlier this month in order to begin inoculating frontline health care staff.
Researchers at UC San Diego School of Medicine, in collaboration with Dutch scientists, have found that certain metabolites — small molecules produced by the process of metabolism — may be predictive indicators for persons at risk for recurrent major depressive disorder.
Researchers find that metabolites — small molecules produced by cellular activities — appear to predict risk of recurring depression and may be a new diagnostic tool
